Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KN019 plus methotrexate in rheumatoid arthritis
CTR20191454Phase 2Completed
- Sponsor
- Alphamab Oncology
- Start
- Jul 2019
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of KN019 in rheumatoid arthritis (RA), sponsored by Alphamab Oncology. Started Jul 2019; status: completed.
02
Drugs
KN019
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20191454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191454.